Skip to main navigation Skip to search Skip to main content

Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment

Research output: Contribution to journal › Article › peer-review

Abstract

PURPOSE: To report the development of a bilateral ocular ischemic syndrome despite corticosteroid treatment in a patient with giant cell arteritis. METHOD: Case report. RESULTS: Despite receiving high-dose intravenous methylprednisolone and oral prednisone for biopsy-proven giant cell arteritis that presented as a severe anterior ischemic optic neuropathy in the right eye, a patient developed progressive ocular ischemia in that eye as well as an ocular ischemic syndrome in the fellow eye. CONCLUSIONS: Some patients with giant cell arteritis, possibly patients with other underlying systemic vasculopathies, are refractory to what should be adequate treatment with systemic corticosteroids and may develop a bilateral ocular ischemic syndrome.

Original languageEnglish (US)
Pages (from-to)102-104
Number of pages3
JournalAmerican journal of ophthalmology
Volume127
Issue number1
DOIs
StatePublished - Jan 1999

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint

Dive into the research topics of 'Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment'. Together they form a unique fingerprint.

Cite this